| For: | Yang H, Luo C, Lan WQ, Tang YH. Vericiguat treatment of heart failure: A systematic review and meta-analysis. World J Clin Cases 2023; 11(35): 8330-8342 [PMID: 38130613 DOI: 10.12998/wjcc.v11.i35.8330] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v11/i35/8330.htm |
| Number | Citing Articles |
| 1 |
Mohamed Bin Zarti, Amna Tamgheli. Safety of Vericiguat in Patients with Coronary Artery Disease: A Systematic Review and Meta-analysis. American Journal of Cardiovascular Drugs 2025; 25(2): 241 doi: 10.1007/s40256-024-00701-0
|
| 2 |
V. Janakiraman, M. Sudhan, Sheikh F. Ahmad, Sabry M. Attia, Talha Bin Emran, Shiek S. S. J. Ahmed. Molecular Docking, Quantum Mechanics and Molecular Dynamics Simulation of Anti-CAD Drugs Against High-Risk Xanthine Dehydrogenase Variants Associated with Oxidative Stress Pathways. Journal of Computational Biophysics and Chemistry 2024; 23(09): 1109 doi: 10.1142/S2737416524500315
|
| 3 |
Michael Gottlieb, Fernanda Bellolio, Brit Long, Alan Storrow. Advances in the management of acute decompensated heart failure. BMJ 2025; 391: e084242 doi: 10.1136/bmj-2025-084242
|
| 4 |
Pedro Gomes Batista, Railla Raquel Albino dos Santos Silva, Marcela Vasconcelos Montenegro, Ramon Huntermann, Maria Eduarda Molinari, Miguel Angel Samaniego, Mrunalini Dandamudi, Caroline O. Fischer Bacca, Juliana Giorgi. Efficacy and safety of vericiguat across the spectrum of heart failure: a systematic review and updated meta‑analysis of randomized controlled trials. European Journal of Clinical Pharmacology 2026; 82(4) doi: 10.1007/s00228-026-04009-7
|
